Genetic and geographical variability in cystic fibrosis: evolutionary considerations - PubMed
Review
. 1996:197:97-114; discussion 114-8.
doi: 10.1002/9780470514887.ch6.
Affiliations
- PMID: 8827370
- DOI: 10.1002/9780470514887.ch6
Review
Genetic and geographical variability in cystic fibrosis: evolutionary considerations
J Bertranpetit et al. Ciba Found Symp. 1996.
Abstract
We have studied cystic fibrosis from an evolutionary perspective by focusing on three main points: the high frequency of cystic fibrosis; the different spectrum of mutations that cause the disease in different areas of Europe; and the age of the delta F508 mutation. Several hypotheses have been suggested to explain the high frequency of cystic fibrosis. We argue that the most plausible is heterozygote resistance to cholera and to other dehydrating intestinal diseases. Different population sizes in the past could explain the higher diversity among cystic fibrosis mutations found in southern Europe. Three microsatellite loci are found close to the delta F508 mutation. The reconstruction of the original microsatellite haplotype in which delta F508 arose, and of the genealogy of the microsatellite haplotypes bearing the mutation, allowed us to date the mutation event at around 50,000 years ago.
Similar articles
-
Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers.
Morral N, Nunes V, Casals T, Chillón M, Giménez J, Bertranpetit J, Estivill X. Morral N, et al. Hum Mol Genet. 1993 Jul;2(7):1015-22. doi: 10.1093/hmg/2.7.1015. Hum Mol Genet. 1993. PMID: 7689896
-
The origin of the major cystic fibrosis mutation (delta F508) in European populations.
Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, Giménez J, Reis A, Varon-Mateeva R, Macek M Jr, Kalaydjieva L, et al. Morral N, et al. Nat Genet. 1994 Jun;7(2):169-75. doi: 10.1038/ng0694-169. Nat Genet. 1994. PMID: 7920636
-
Claustres M, Desgeorges M, Moine P, Morral N, Estivill X. Claustres M, et al. Hum Genet. 1996 Sep;98(3):336-44. doi: 10.1007/s004390050219. Hum Genet. 1996. PMID: 8707306
-
Do delta F508 heterozygotes have a selective advantage?
Wiuf C. Wiuf C. Genet Res. 2001 Aug;78(1):41-7. doi: 10.1017/s0016672301005195. Genet Res. 2001. PMID: 11556136
-
[Detection of delta F508 mutation in cystic fibrosis].
Fekete G, Váradi A, Pipiras E, Németh K, Réthy LA, Holics K, Ujhelyi R. Fekete G, et al. Orv Hetil. 1992 Sep 20;133(38):2423-4, 2427-30. Orv Hetil. 1992. PMID: 1408077 Review. Hungarian.
Cited by
-
Högenauer C, Santa Ana CA, Porter JL, Millard M, Gelfand A, Rosenblatt RL, Prestidge CB, Fordtran JS. Högenauer C, et al. Am J Hum Genet. 2000 Dec;67(6):1422-7. doi: 10.1086/316911. Epub 2000 Oct 30. Am J Hum Genet. 2000. PMID: 11055897 Free PMC article. Clinical Trial.
-
Evaluating candidate agents of selective pressure for cystic fibrosis.
Poolman EM, Galvani AP. Poolman EM, et al. J R Soc Interface. 2007 Feb 22;4(12):91-8. doi: 10.1098/rsif.2006.0154. J R Soc Interface. 2007. PMID: 17015291 Free PMC article.
-
Evolutionary dynamics of the human ABO gene.
Calafell F, Roubinet F, Ramírez-Soriano A, Saitou N, Bertranpetit J, Blancher A. Calafell F, et al. Hum Genet. 2008 Sep;124(2):123-35. doi: 10.1007/s00439-008-0530-8. Epub 2008 Jul 16. Hum Genet. 2008. PMID: 18629539
-
Tishkoff SA, Pakstis AJ, Stoneking M, Kidd JR, Destro-Bisol G, Sanjantila A, Lu RB, Deinard AS, Sirugo G, Jenkins T, Kidd KK, Clark AG. Tishkoff SA, et al. Am J Hum Genet. 2000 Oct;67(4):901-25. doi: 10.1086/303068. Epub 2000 Sep 13. Am J Hum Genet. 2000. PMID: 10986042 Free PMC article.
-
Personalized medicine and human genetic diversity.
Lu YF, Goldstein DB, Angrist M, Cavalleri G. Lu YF, et al. Cold Spring Harb Perspect Med. 2014 Jul 24;4(9):a008581. doi: 10.1101/cshperspect.a008581. Cold Spring Harb Perspect Med. 2014. PMID: 25059740 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous